Research Articles on Tuberculosis from 1940 onwards

Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfectedwith HIV.
Antimicrob Agents Chemother. 2014 Jun;58(6):3468-74.
Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNAPolymerase Beta Subunit of Mycobacterium tuberculosis.
J Cell Biochem. 2017 Dec;118(12):4594-4606.
Mutations outside the rifampicin resistance-determining region associated with rifampicinresistance in Mycobacterium tuberculosis.
J Antimicrob Chemother. 2011 Apr;66(4):730-3.
Anti-mycobacterial activities of synthetic cationic ?-helical peptides and their synergism with rifampicin
Biomaterials. 2014 Feb;35(6):2032-8.
Altered fatty acid metabolism due to rifampicin-resistance conferring mutations in the rpoB Geneof Mycobacterium tuberculosis: mapping the potential of pharmaco-metabolomics for globalhealth and personalized medicine.
OMICS. 2012 Nov;16(11):596-603.
Isoniazid and Rifampicin as Therapeutic Regimen in the Current Era: A Review
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2013 Feb;57(2):893-900.
The challenge of new drug discovery for tuberculosis.
Nature. 2011 Jan 27;469(7331):483-90.
Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-?-D-arabinose biosynthetic and utilization pathway genes.
Nat Genet. 2013 Oct;45(10):1190-7.
Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistantMycobacterium tuberculosis.
J Clin Microbiol. 2011 Jul;49(7):2502-8.